Skin Cancer Evaluation. Simplified.
- Tweets 541
- Following 254
- Followers 212
- Likes 68
DermaSensor, Inc. retweeted
A great reminder that preventive care and regular skin checks should not be overlooked. Planning ahead can make it easier to stay on top of routine screenings and skin health throughout the year.
1
1
9
Before schedules fill up, get your annual physicals, screenings, and skin checks on the calendar.
A little planning now = easier preventive care before the holiday rush.
Need a provider? Use the DermaSensor Physician Finder (link in bio) to find one near you.
1
1
37
For cancer survivors, staying proactive about skin health brings extra reassurance. In this patient testimonial, hear how simple the DermaSensor assessment felt and how it added confidence to their skin check. Find a physician near you at the link in bio.
11
Summer's over, but sun damage can linger. As fall physicals ramp up, make skin checks part of the visit, especially when a suspicious lesion comes up.
DermaSensor pairs elastic scattering spectroscopy + AI for an immediate result at point of care.
dermasensor.com
22
Primary care is often where suspicious skin lesions are first noticed. DermaSensor brings objective, real-time data into the exam room to support risk assessment when it matters most. Learn more via the link in bio.
1
2
25
More practices are adding DermaSensor, and the clinical value speaks for itself: 96% sensitivity, FDA cleared, non-invasive, immediate results. Objective skin cancer risk data at the point of care, without slowing down the visit. Link in bio to learn more.
1
17
Summer's ending, but UV damage doesn't. Repeated sunburns raise skin cancer risk, including melanoma. Watch for spots that are new, changing, or concerning. DermaSensor gives clinicians an AI-powered, non-invasive tool for real-time skin cancer risk assessment. Link in bio.
23
Health equity matters in skin cancer detection. DermaSensor's AI analyzes 47 wavelengths per lesion. DERM-SUCCESS study: 95.5% sensitivity overall, 96.5% in Fitzpatrick I-III, 92.2% in IV-VI. Innovation + evidence = equitable care. Link in bio.
#DermaSensor #HealthEquity
19
DermaSensor, Inc. retweeted
What if you could assess a mole for skin cancer risk in 30 seconds or less?
That's exactly what this Miami-based company does with its FDA-approved device. Learn more about how it works in our latest episode of the Miami Tech Pod.
🎧 Listen to the full episode — link in bio.
@DermaSensor @codyVsimmons
2
1
118
DermaSensor, Inc. retweeted
PCPs miss UP TO HALF of melanoma cases, and only 3-5% of biopsies are actually melanoma.
Learn how this Miami company is helping PCP's better detect skin cancer while also helping avoid unnecessary biopsies.
🎧 Listen to the full episode — link in bio.
@DermaSensor @codyVsimmons
1
3
1
191
DermaSensor, Inc. retweeted
He didn't start DermaSensor. He got the call in 2016, said yes, and didn't stop until the FDA said yes too.
Our cover story on @dermasensor
yespress.io/cody-simmons?utm… via Yespress
1
1
1
22
Hear it directly from the physicians using DermaSensor. Providers across the country share how it boosts confidence assessing suspicious lesions, strengthens clinical decision-making, and creates clearer patient conversations.
Link in bio to learn more or request a demo.
27
September means busier schedules and faster visits. DermaSensor gives providers an AI-powered, non-invasive tool to assess suspicious skin lesions in real time, fitting into clinical workflow without adding complexity. Learn more about DermaSensor.
20
September is Skin Care Awareness Month, a reminder to make skin health part of everyday care. Check your skin regularly and talk to your provider about anything new or changing. Providers: see how DermaSensor supports skin cancer risk assessment at the point of care. Link in bio.
17
Proud to be named a CIO Bulletin Leading Company to Watch 2026! This honor reflects our team's work advancing AI-powered skin health tech and expanding point-of-care access. Grateful for the journey and excited for what's next.
#DermaSensor #MedTech #DigitalHealth #AI
14
Expanding access. Advancing care.
We've announced four new strategic partnerships bringing DermaSensor's AI-powered skin cancer technology to more healthcare providers, from primary care to federal health systems and national distribution.
Learn more at DermaSensor.com.
11
AI in skin cancer detection raises real questions. The truth: it's not replacing clinicians; it's supporting them with real-time insights at the point of care. DermaSensor helps assess suspicious lesions with non-invasive tech built for everyday workflows. dermasensor.com
27
Congrats to Cody Simmons, CEO of DermaSensor, on being named a 2026 Titan 100 Honoree, recognizing Miami's top CEOs. His leadership continues to drive our mission to expand access to AI-powered skin cancer detection tools for clinicians. Proud of this well-deserved recognition!
17
DermaSensor, Inc. retweeted
~90 million Americans at risk of getting skin cancer aren't getting checked.
Learn how this Miami-based company is setting out to change that.
🎧 Listen to the full episode — link in bio.
@DermaSensor @codyVsimmons
3
1
197